Site Search

Share

X

Search Results

Cancer Survivors Connect with New York State Lawmakers for ‘Cancer Action Day’

... Hunter have been invaluable allies in our mission to reduce the cancer burden across New York. Their leadership in expanding access to biomarker testing and removing barriers to cancer screening have brought hope into patients’ lives and equity into conversations around cancer care. ACS ...

Connecticut State Lead Ambassador

... of cancer. We have worked really hard on tobacco control in our state; and that will be an ongoing fight. A victory this year was passing a biomarker testing bill for Medicaid. Going forward, we will work to pass this for private insurers. On the federal level, we are very fortunate to have the ...

CEO of the American Cancer Society and ACS CAN Announces Transition Plans

... cancer prevention and care. Notable policy wins include federal coverage for patient navigators, and state level wins to ensure access to biomarker testing.  In addition to these achievements, a hallmark of Knudsen’s tenure at ACS was significant growth in strategic partnerships and ...

Advocates Set Sights on Cancer Prevention & Detection in 2024, Respond to Governor’s Budget with Avenues to Reduce Cancer Burden in NY

... Relations Director Michael Davoli: “In 2023, New York State delivered for its residents, prioritizing access to care with the passage of the biomarker testing bill. This legislation will equip countless New Yorkers who have received a cancer diagnosis with critical information about their disease ... their voices heard, ACS CAN influences legislative and regulatory solutions that will end cancer as we know it.  0 Four weeks after historic biomarker testing bill was signed into law, ACS CAN reacts to Governor’s budget and unveils its legislative vision for 2024 Advocates Set Sights ...

American Cancer Society and ACS CAN Statement: White House’s Cancer Moonshot National Cancer Plan

... such as the Breast & Cervical Cancer Early Detection Program and accelerate access to innovation through reimbursement strategies ( e.g. biomarker testing). No Untreatable Cancers: Investment in fundamental science produces effective new approaches to precision cancer treatment, particularly ...

December 2015 Advocacy Update

Barriers to Patient Enrollment in Therapeutic Clinical Trials for Cancer

... more highly associated with demographic or socioeconomic subgroup unless specific rationale for exclusion exists. Encourage broad-panel biomarker testing programs to help promote simultaneous pre-screening for multiple targeted therapy trials. Develop and share resources that can be used for ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy